Monday 09 November 2026About PsychregWrite for Us

Health

Cell Recycling Machines Reveal Surprise Role in Fighting Infections

by Psychreg News Team ·

immune system

Proteasomes, the cellular machines responsible for breaking down proteins, have been found to play a surprising role in immune defence. A study published in Nature has revealed that these structures generate defence peptides capable of combating bacterial infections, offering a potential new avenue for antibiotic development.

For decades, proteasomes were primarily understood as part of the cellular recycling system, breaking down damaged or unneeded proteins. But researchers have discovered that they also produce antimicrobial peptides during protein degradation. These peptides, termed proteasome-derived defence peptides, appear to be generated constantly within cells and are further increased when bacteria invade. Unlike conventional antimicrobial peptides, which are typically encoded in the genome and require activation through enzymatic processing, these newly identified peptides arise from protein breakdown, suggesting an additional layer of innate immunity.

The study found that the production of these defence peptides is regulated by a proteasome-associated protein called PSME3. When bacterial infections occur, PSME3 modifies the proteasome’s activity, enhancing its ability to generate antimicrobial peptides. These peptides exhibit strong antibacterial properties by disrupting the membranes of invading bacteria, thereby impeding their ability to multiply and cause infection.

Lead researcher Yifat Merbl, PhD, principal investigator at the Weizmann Institute of Science, emphasised the significance of this discovery. “Before now, we knew nothing about the connection between proteasome products and the production of these peptides. In light of our findings, we conducted an extensive series of experiments demonstrating that the proteasomes are key to this defence system.”

Using computational models, researchers analysed human proteins to predict how widely this defence mechanism could operate. Their results suggest that most proteins in the body contain sequences that could potentially give rise to antimicrobial peptides after degradation. This raises the possibility that proteasome-derived defence peptides play a broader role in immune protection than previously thought, providing a widespread, naturally occurring defence against pathogens.

The discovery of this mechanism has significant implications for medicine and biotechnology. Antibiotic resistance is a growing global crisis, and there is an urgent need for new approaches to combat bacterial infections. Identifying and harnessing naturally occurring antimicrobial peptides from the proteasome could lead to the development of innovative treatments. Unlike traditional antibiotics, which target specific bacterial structures and can lead to resistance over time, these peptides work by disrupting bacterial membranes, a strategy that bacteria find more difficult to counteract.

Merbl highlighted the potential clinical applications of these findings. “This peptide database opens a new frontier for developing personalised treatments against infections and other medical conditions. Natural peptides could be tailored to strengthen immune defences in patients with weakened immunity, such as organ transplant recipients or cancer patients.”

Beyond bacterial infections, the study raises questions about how proteasome-derived defence peptides might function in other immune-related processes. Previous research has linked proteasome activity to immune system regulation, and these new findings suggest that their role extends far beyond what was previously understood. Further investigation is needed to determine whether similar mechanisms exist for combating viral or fungal infections and whether proteasome-derived defence peptides can be modified for therapeutic use.

“The ability to track how the activity of the proteasome changes in response to bacterial infection was based on the technology we developed several years ago,” said Karin Goldberg, PhD student and lead researcher on the project. “The turning point came when we saw that the proteasome’s peptide-cutting activity changed during infection. That was when we realised we had uncovered a previously unknown immune mechanism.”